English 
Español 
français 
العربية Search
Search
Ozagrel is used for cerebral spasm after subarachnoid hemorrhage and cerebral ischemia symptoms with cerebral spasm, as well as improvement of movement disorders associated with the acute phase of cerebral thrombosis.
Ozagrel has inhibitory effect on platelet aggregation caused by different inducers, can inhibit TXA2 synthetase, promote the production of PGI2, has anti-platelet aggregation and anti-vasospasm effect, can inhibit cerebral thrombosis and cerebral vasospasm. Ozagrel is mainly suitable for the improvement of cerebral vascular contracture and complicated by cerebral ischemia after subarachnoid hemorrhage. It can reduce fibrin, coagulation factor I in patients with cerebral infarction, have the effect of reducing blood viscosity, and inhibit platelet aggregation.
| Items | Specification |
| Product name | Ozagrel |
| CAS | 82571-53-7 |
| Appearance | White crystal or crystalline powder |
| Assay | ≥99% |
| Molecular Formula | C13H12N2O2 |
| Molecular Weight | 228.25 |
| EINECS | 919-112-4 |
| Product parameters | |
| Cas number: | 82571-53-7 |
| Appearance: | White crystal or crystalline powder |
| Purity: | 99%min |
| Package details: | 1kg/foil bag;25kg/drum |
| Brand: | Fortunachem |
Guaranteed purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
